APA (7th ed.) Citation

Alatawi, Y., Alanazi, F. E., Alattar, A., Alshaman, R., Ramadan, Y. N., Sayad, R., & Hetta, H. F. (2025). Therapeutic Impact of Zanubrutinib in Chronic Lymphocytic Leukemia: Evidence from a Systematic Review and Single-Arm Meta-Analysis. Pharmaceuticals (14248247), 18(11), 1674. https://doi.org/10.3390/ph18111674

Chicago Style (17th ed.) Citation

Alatawi, Yasser, Fawaz E. Alanazi, Abdullah Alattar, Reem Alshaman, Yasmin N. Ramadan, Reem Sayad, and Helal F. Hetta. "Therapeutic Impact of Zanubrutinib in Chronic Lymphocytic Leukemia: Evidence from a Systematic Review and Single-Arm Meta-Analysis." Pharmaceuticals (14248247) 18, no. 11 (2025): 1674. https://doi.org/10.3390/ph18111674.

MLA (9th ed.) Citation

Alatawi, Yasser, et al. "Therapeutic Impact of Zanubrutinib in Chronic Lymphocytic Leukemia: Evidence from a Systematic Review and Single-Arm Meta-Analysis." Pharmaceuticals (14248247), vol. 18, no. 11, 2025, p. 1674, https://doi.org/10.3390/ph18111674.